NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Researchers report details of new studies and findings in the area of breast cancer



March 2nd, 2006

Breast cancer data are the focus of recent research from the Hong Kong, United Kingdom and Italy.

Study 1: Mapping for sentinel lymph node biopsy is enhanced with combined diagnostic modalities.

"Use of blue dye alone as a marker for sentinel lymph node (SLN) biopsy is effective, but combining it with isotope marking can improve the success rate," proposed scientists in Hong Kong. "Use of the isotope adds extra cost and there are potential radiation hazards."

W.K. Hung and colleagues of Kwong Wah Hospital wrote, "The two techniques were compared in a randomized trial. Women with early breast cancer (less than 3 cm) and no palpable...


Source: Women's Health Weekly (2006-03-02)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login